Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures

NCT07505004 is registered in ClinicalTrials.gov with Praxis Precision Medicines as lead sponsor.

NCT NCT07505004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07505004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures
Lead sponsor
Praxis Precision Medicines
Phase
Phase 3
Overall status
Active, not recruiting
Start date
January 29, 2026
Completion date
May 31, 2027
Enrollment
300 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

focal epilepsy